Amplitude Surgical’s Foot and Ankle Sales Continue Growth Despite Pandemic
The company's foot and ankle business continued its steady growth in FY 3Q21, offsetting some impact from COVID's third wave in Europe. Apr 26, 2021
We've found 292 results
Calvin Lin Shares Insight on Prioritizing and Partnering
Mr. Lin has led the U.S. operations for United Orthopedic for more than a decade. He has learned that trust and people are the most critical factors in a successful business. Apr 22, 2021
4 Spine Acquisitions from 1Q21
The heavily player-populated spine market continues to be an active space for mergers and acquisitions, as companies of all sizes seek to build out their implant and technology portfolios. Four of the six publicly announced orthopedic OEM transactions we tracked in 1Q21 were spine-related. Apr 21, 2021
DePuy Synthes Exceeds Expectations in the First Quarter
The company grew 3.7% in 1Q21, driven by market recovery, improved organization execution and new product launches. Apr 21, 2021
Orthopedics Remained Hobbled by Surgical Restrictions in 1Q21
The first quarter of 2021 began amid COVID's deadliest surge. However, encouraging signs point toward a second half recovery. Apr 19, 2021
Biocomposites Launches Biocomposites Companion App
The app puts user information in the hands of healthcare professionals to support STIMULAN and genex at point of use. Mar 30, 2021
SeaSpine Announces Agreement to Acquire 7D Surgical
The company will purchase all issued and outstanding shares of 7D Surgical for $110 million with a 2Q21 expected close. Mar 22, 2021
Orthopedic Market Limped to Finish Line in 2020
We estimate the orthopedic market declined in the low single digits for 4Q20 and in the low double-digits for the full year 2020. Mar 17, 2021
SeaSpine Expects 20% Growth in 2021
The company capped 2020 with record revenues in the fourth quarter, and expects that momentum to continue in 2021. Mar 08, 2021
ATEC Closes Record 2020, Takes Aim at Spine Giants
The company grew +28% in 2020 despite the pandemic and expects to grow another +25% in 2021 as it continues building clinical distinction. Mar 05, 2021
